Case Study: City of Hope accelerates breast cancer biomarker analysis with DNAnexus

City of Hope cuts biomarker analysis from 3 days to under 2 hours with DNAnexus

City of Hope, a cancer research and treatment organization, faced the challenge of creating a scalable and uniform system for precision oncology analysis across multiple clinical trial sites. They partnered with vendor DNAnexus to build a cloud-based platform, POSEIDON, to empower their scientists and clinicians.

The DNAnexus technology stack provided a secure, compliant, and unified cloud environment. This solution standardized the biomarker analysis workflow, drastically slashing processing times from three days to under two hours. DNAnexus enabled accessible reporting and a locked-down, auditable pipeline for clinical trials.

City of Hope